close
NasdaqCM - Delayed Quote USD

Cardio Diagnostics Holdings, Inc. (CDIO)

2.0300 +0.0150 (+0.74%)
At close: September 11 at 4:00:00 PM EDT
2.0300 0.0000 (0.00%)
After hours: September 11 at 7:30:06 PM EDT
Chart Range Bar
Loading chart for CDIO
  • Previous Close 2.0150
  • Open 2.0500
  • Bid 1.4600 x 200
  • Ask 2.6700 x 200
  • Day's Range 1.9800 - 2.0900
  • 52 Week Range 0.9700 - 7.9100
  • Volume 25,114
  • Avg. Volume 58,732
  • Market Cap (intraday) 6.008M
  • Beta (5Y Monthly) 2.23
  • PE Ratio (TTM) --
  • EPS (TTM) -2.9000
  • Earnings Date (est.) Nov 6, 2026
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est --

Cardio Diagnostics Holdings, Inc. develops and commercializes epigenetics-based clinical tests for cardiovascular disease. The company offers Epi+Gen CHD, a three-year symptomatic coronary heart disease (CHD) risk assessment clinical blood test targeting CHD events, including heart attacks; PrecisionCHD, an integrated epigenetic-genetic clinical blood test for the detection of coronary heart disease; and Actionable Clinical Intelligence, a platform that offers new epigenetic and genetic insights to clinicians prescribing to help improve chronic care management. It also provides CardioInnovate360, a research-use-only solution to support the discovery, development and validation of novel biopharmaceuticals for the assessment and management of cardiovascular diseases; and HeartRisk, a SaaS cardiovascular disease risk intelligence platform. It serves telemedicine providers; provider organizations, such as concierge practices, longevity clinics, and risk-bearing provider organizations; and employer organizations. Cardio Diagnostics Holdings, Inc. was founded in 2017 and is headquartered in Chicago, Illinois.

cdio.ai

15

Full Time Employees

December 31

Fiscal Year Ends

Recent News

View More

Performance Overview

Trailing total returns as of 9/11/2026, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .

YTD Return

CDIO
25.09%
S&P 500 (^GSPC)
11.85%

1-Year Return

CDIO
46.91%
S&P 500 (^GSPC)
16.24%

3-Year Return

CDIO
83.89%
S&P 500 (^GSPC)
70.63%

5-Year Return

CDIO
99.31%
S&P 500 (^GSPC)
71.74%

Earnings Trends

View More

Earnings Per Share

GAAP
Normalized
GAAP
Normalized
 

Revenue vs. Earnings

Annual
Quarterly
Annual
Quarterly
Q1 FY25
Revenue 940
Earnings -1.64M
Profit Margin -173,942.55%

Q2

FY24

Q3

FY24

Q4

FY24

Q1

FY25

-2M
-1M
-500K
0
-150000.0%
-100000.0%
-50000.0%
 

Statistics

View More

Valuation Measures

Annual
  • Market Cap

  • Enterprise Value

  • Trailing P/E

  • Forward P/E

  • PEG Ratio (5yr expected)

  • Price/Sales (ttm)

  • Price/Book (mrq)

  • Enterprise Value/Revenue

  • Enterprise Value/EBITDA

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    0.00%

  • Return on Assets (ttm)

    -44.06%

  • Return on Equity (ttm)

    -75.44%

  • Revenue (ttm)

    14.45k

  • Net Income Avi to Common (ttm)

    -6.47M

  • Diluted EPS (ttm)

    -2.9000

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    5.59M

  • Total Debt/Equity (mrq)

    4.98%

  • Levered Free Cash Flow (ttm)

    -3.77M

Compare

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Company Insights

Research Reports

View More

People Also Watch